Cystic fibrosis (CF) lung disease is characterized by chronic colonization/infection of the airways by a variety of bacteria, including H. influenzae, S. aureus, P. aeruginosa and other Gram negatives. For CF most patients, the lung disease begins soon after birth. Bacteria grow in areas of the lung that are normally sterile and the clinical course correlates with the acquisition of bacterial infection and its progression. While the pathogenic mechanisms linking CFTR mutations to CF lung disease continue to be a subject of research and debate, it is widely accepted that the normal host defense barriers in the lung are breached. Whatever the cause underlying this propensity for infection, it is lung specific. The result is a characteristic susceptibility to bacterial infection. These features indicate that CF impairs the innate defenses of the lung. Our laboratory is particularly interested in understanding the host defense contributions of newly discovered beta-defensins and novel proteins of the lipid transfer/lipopolysaccharide binding protein (LT/LBP) family. We hypothesize that a subset of the beta-defensin and LT/LBP genes are expressed in airway epithelia and play roles in innate host defense through their antimicrobial and/or lipid binding properties. There are two aims.
The first aim will determine which beta-defensin peptides contribute to innate immunity in the airways and characterize their host defense activities.
The second aim will investigate how members of the LT/LBP family contribute to innate immunity. We hypothesize that they exert BPI-like antimicrobial/anti-inflammatory activities in the airways. Addressing these aims will further our understanding of the role products of these two gene families play in the pulmonary innate immune system. By increasing our knowledge of the antimicrobial components of the innate immune system we may gain insights into CF lung disease pathogenesis and devise new therapeutic approaches.
| Bartlett, Jennifer A; Meyerholz, David K; Wohlford-Lenane, Christine L et al. (2015) Increased susceptibility to otitis media in a Splunc1-deficient mouse model. Dis Model Mech 8:501-8 |
| Bartlett, Jennifer A; Albertolle, Matthew E; Wohlford-Lenane, Christine et al. (2013) Protein composition of bronchoalveolar lavage fluid and airway surface liquid from newborn pigs. Am J Physiol Lung Cell Mol Physiol 305:L256-66 |
| Reed, Matthew D; McCombie, Barbara E; Sivillo, Aimee E et al. (2012) Safety assessment of nebulized xylitol in beagle dogs. Inhal Toxicol 24:365-72 |
| Dong, Qian; Ostedgaard, Lynda S; Rogers, Christopher et al. (2012) Human-mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-?F508 processing and alter its gating defect. Proc Natl Acad Sci U S A 109:917-22 |
| Pezzulo, Alejandro A; Starner, Timothy D; Scheetz, Todd E et al. (2011) The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am J Physiol Lung Cell Mol Physiol 300:L25-31 |
| Schmidt, Nathan W; Mishra, Abhijit; Lai, Ghee Hwee et al. (2011) Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc 133:6720-7 |
| Bartlett, Jennifer A; Bartlett, Jennifer; Gakhar, Lokesh et al. (2011) PLUNC: a multifunctional surfactant of the airways. Biochem Soc Trans 39:1012-6 |
| Itani, Omar A; Chen, Jeng-Haur; Karp, Philip H et al. (2011) Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance. Proc Natl Acad Sci U S A 108:10260-5 |
| Fischer, Anthony J; Lennemann, Nicholas J; Krishnamurthy, Sateesh et al. (2011) Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide. Am J Respir Cell Mol Biol 45:874-81 |
| Gakhar, Lokesh; Bartlett, Jennifer A; Penterman, Jon et al. (2010) PLUNC is a novel airway surfactant protein with anti-biofilm activity. PLoS One 5:e9098 |
Showing the most recent 10 out of 77 publications
